New Estimates Reveal: 1 In 5 People Worldwide Will Develop Cancer

Blogs

New Estimates Reveal: 1 in 5 People Worldwide Will Develop Cancer

5th Feb 2024 by Admin 222

New data from the World Health Organization (WHO) underscores the urgency of cancer prevention. Learn about the most common cancer types, their impact, and how to stay informed.

The Growing Burden of Cancer

In 2022 alone, there were approximately 20 million new cancer cases reported globally, resulting in 9.7 million deaths. These staggering numbers highlight the relentless march of cancer, affecting individuals across continents and demographics. But what lies behind this alarming trend?

The Disproportionate Impact

Cancer doesn’t discriminate. Yet, it disproportionately affects underserved populations. The urgent need to address cancer inequities is evident. As part of universal health coverage (UHC), countries must prioritize cancer management and palliative care services. Shockingly, only 39% of participating countries currently cover the basics of cancer management in their core health services for all citizens1.

The Top Culprits: Lung, Breast, and Colorectal Cancers

The IARC’s Global Cancer Observatory sheds light on the most common cancer types. In 2022, these three cancers collectively accounted for two-thirds of new cases and deaths worldwide:

Lung Cancer: With 2.5 million new cases, lung cancer topped the list, fueled by persistent tobacco use in Asia.
Breast Cancer: Affecting 2.3 million women, breast cancer remains a significant threat.
Colorectal Cancer: Responsible for 1.9 million cases, colorectal cancer demands attention.

The Grim Reaper: Leading Causes of Cancer Death

When it comes to mortality, lung cancer takes the lead, claiming 1.8 million lives globally. Other formidable foes include:

Colorectal Cancer: Responsible for 900,000 deaths.
Liver Cancer: Taking 760,000 lives.
Breast Cancer: Causing 670,000 deaths.

The Role of HPV and Vaccination

Human papillomavirus (HPV) plays a significant role in cervical cancer, but it’s also linked to other cancers. Vaccination against HPV is crucial. India’s Cervavac, targeting the four most common cancer-causing HPV types, is now available. The cost? Approximately Rs 2,000 per dose1.

Disclaimer: This article is intended for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.